Literature DB >> 20888191

Adolescent escitalopram administration modifies neurochemical alterations in the hippocampus of maternally separated rats.

Jiaojie Hui1, Zhijun Zhang, Shanshan Liu, Guangjun Xi, Xiangrong Zhang, GaoJun Teng, Kevin C Chan, Ed X Wu, Binbin Nie, Baoci Shan, Lingjiang Li, Gavin P Reynolds.   

Abstract

Early life stress is a potential precursor of eventual neuropsychiatric diseases and may result in altered neurodevelopment and function of the hippocampus, which thus provides a site at which potential interventions to modify the effects of early life stress may act. In this study, Sprague-Dawley rat pups comprising male and female animals underwent maternal separation (MS) for 180 min from postnatal days (PND) 2 to 14, or were left with their dams. They subsequently received daily administration of saline (0.9%), escitalopram (10 mg/kg), or no treatment during adolescence (PND 43-60). All adult animals underwent brain magnetic resonance imaging (MRI) and bilateral hippocampal proton magnetic resonance spectroscopy ((1)H-MRS). Neither MS nor escitalopram treatment had a significant effect on hippocampal volume. Adult rats that experienced MS displayed significantly increased choline-containing compounds (Cho) and decreased N-acetylaspartate (NAA), glutamate (Glu) and Myo-inositol (MI) relative to the stable neurometabolite creatine (Cr) in hippocampus. Administration of escitalopram during adolescence could modify the alterations of NAA/Cr, Glu/Cr and MI/Cr. The effects of MS on hippocampal neurochemistry were most significant in the right hippocampus. These results indicate that MS in rats has long-term consequences on hippocampal neurochemistry reflective of neural density/functional integrity, especially on the right hippocampus, and adolescent administration with escitalopram can at least partially ameliorate these neurochemical alterations. Furthermore, these metabolite changes seem to be more sensitive indicators of the results from early life stress than volume changes.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888191     DOI: 10.1016/j.euroneuro.2010.08.010

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  6 in total

1.  Chronic Escitalopram Treatment Does Not Alter the Effects of Neonatal Stress on Hippocampal BDNF Levels, 5-HT1A Expression and Emotional Behaviour of Male and Female Adolescent Rats.

Authors:  Lorena Henn; Natália C Zanta; Carlos Eduardo N Girardi; Deborah Suchecki
Journal:  Mol Neurobiol       Date:  2020-10-15       Impact factor: 5.590

Review 2.  Neuroinflammation, Early-Life Adversity, and Brain Development.

Authors:  Susan L Andersen
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

3.  Behavioral deficits, abnormal corticosterone, and reduced prefrontal metabolites of adolescent rats subject to early life stress.

Authors:  Jie Zhang; Chadi G Abdallah; Yaowen Chen; Tianhua Huang; Qingjun Huang; Chongtao Xu; Yeyu Xiao; Yuzhen Liu; Yan Ding; Renhua Wu
Journal:  Neurosci Lett       Date:  2013-05-02       Impact factor: 3.046

4.  Learning and memory alterations are associated with hippocampal N-acetylaspartate in a rat model of depression as measured by 1H-MRS.

Authors:  Guangjun Xi; Jiaojie Hui; Zhijun Zhang; Shanshan Liu; Xiangrong Zhang; Gaojun Teng; Kevin C Chan; Ed X Wu; Binbin Nie; Baoci Shan; Lingjiang Li; Gavin P Reynolds
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 5.  Recent Advances in Translational Magnetic Resonance Imaging in Animal Models of Stress and Depression.

Authors:  Allison L McIntosh; Shane Gormley; Leonardo Tozzi; Thomas Frodl; Andrew Harkin
Journal:  Front Cell Neurosci       Date:  2017-05-24       Impact factor: 5.505

Review 6.  Modulation of early stress-induced neurobiological changes: a review of behavioural and pharmacological interventions in animal models.

Authors:  E L Harrison; B T Baune
Journal:  Transl Psychiatry       Date:  2014-05-13       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.